JPRN-UMIN000029175招募中未知
The pharmacokinetic analysis and safety of sirolimus treatment for pediatric patients with intractable vascular anomalies - The pharmacokinetic analysis of sirolimus for pediatric patients with intractable vascular anomalies
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with a history of hypersensitivity to ingredients of this drug 2. Patients with serious liver and renal disorders 3. Patients with symptoms that affect cytokine value of such obvious infection at the time of specimen collection 4. Patients must also avoid strong inducers of CYP3A4 5. Past usage of mTOR inhibitors or other molecular target drugs relating mTOR pathway 6. Patient who is judged inappropriate to participate in this study by the investigators
研究者
相似试验
已完成
3 期
Comparison of the Effects of Oral Sirolimus and Oral Cyclosporine on the Thrombocytopenic Chronic PurpuraImmune thrombocytopenic purpuraIRCT20180501039499N1Arak University of Medical Sciences60
已完成
不适用
Clinical study on efficacy and safety of sirolimus against epileptic seizures of focal cortical dysplasia type IIPatients with epilepsy with focal cortical dysplasia type 2JPRN-UMIN000030962Hokkaido University Hospital2
招募中
1 期
Evaluation of intravenous or subcutaneous administration of ublituximab in patients with multiple sclerosisCTIS2023-509555-13-00Tg Therapeutics Inc.60
招募中
不适用
Safety and Efficacy of the FANTOM ENCORE sirolimus-eluting bioresorbable scaffold for treatment of de-novo coronary artery disease: the ENCORE-I studyCoronary artery disease. Coronary atherosclerosis10011082NL-OMON49058Trialbureau Cardiologie26
Unknown
4 期
The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant PatientsTransplantationKidney TransplantationImmunosuppressionNCT00166816National Taiwan University Hospital40